Appraisal suspended
Indication |
|
| Status: Suspended | |
For the treatment of the following infections in adults: acute bacterial skin and skin structure infections (ABSSSI); community-acquired pneumonia (CAP), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines. |
|
Medicine details |
|
| Medicine name | delafloxacin (Quofenix®) |
| Formulation | 300 mg powder for concentrate for solution for infusion; 450 mg tablet |
| Reference number | 4402 |
| Indication | As above |
| Company | A. Menarini Farmaceutica Internazionale SRL |
| BNF chapter | Infections |
| Submission type | Full |
| Status | Suspended |
| NMG meeting date | 13/04/2022 |
| AWMSG meeting date | 17/05/2022 |
| Date of issue | TBC |
| Further information AWMSG position statement on the appraisal of antimicrobial medicines |
|